Ghrelin, IGF-I and IGFBP-3 levels in children with type 1 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 12, 2005, Pages 1433-1439

  Bideci, Aysun ^a,b   Çamurdan, M Orhun ^a   Cinaz, Peyami ^a   Demirel, Fatma ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Asagi Eglence Mendil Sokak Akdeniz   (Turkey)

Author keywords

Children; Ghrelin; IGF 1; IGFBP 3; Type 1 diabetes mellitus

Indexed keywords

GHRELIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PROTEIN BLOOD LEVEL; PUBERTY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

EID: 30944462958     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.12.1433     Document Type: Article

References (33)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghengi R, Camanni F, Ghigo E. Preliminary evidence that ghrelin, the natural secretagogue receptor ligand, strongly stimulates growth hormone secretion in humans. J Endocrinol Invest 2000; 23: 493-495.
3. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
4. Casanueva FF, Dieguez C. Ghrelin: the link connecting growth with metabolism and energy homeostasis. Rev Endocr Metab Disord 2002; 3: 325-338.
5. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003; 52: 918-921.
6. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 2001; 281: 1220-1225.
7. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227-232.
8. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K. Stomach is a major source of circulating ghrelin and feeding state determines plasma ghrelin-like immunoreactivty levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758.
9. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJS, Smith RG, Van der Ploeg LH, Howard AD. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997; 48: 23-29.
10. Karbonits M, Gueorguiev M, O'Grady E, Lecoeur C, Swan DC, Mein CA, Weill J, Grossman AB, Froguel P. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab 2002; 87: 4005-4008.
11. Dunger DB, Acerini CL. IGF-I and diabetes in adolescence. Diabetes Metab 1998; 24: 101-107.
12. Ostergard T, Hansen TK, Nyholm B, Grauholt CH, Djurhuus CB, Hosoda H, Kangawa K, Schmitz O. Circulating ghrelin concentrations are reduced in healthy offspring of type 2 diabetic subjects, and are increased in women independent of a family history of type 2 diabetes. Diabetologia 2003; 46: 134-136.
13. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
14. Lucidi P, Murdolo G, Di Loreto C, De Cicco A, Parlanti N, Faneli C, Santeusanio F, Bolli GB, De Feo P. Ghrelin is not necessary for adequate hormonal counter-regulation of insulin-induced hypoglycemia. Diabetes 2002; 51: 2911-2914.
15. Saad MF, Bernaba B, Hwu C, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997-4000.
16. Holdstock C, Ludvigsson J, Karlsson FA. Abnormal ghrelin secretion in new onset childhood type 1 diabetes. Diabetologia 2004; 47: 150-151.
17. Soriano-Guillen L, Barrios V, Lechuga-Sancho A, Chowen JA, Argente J. Response of circulating ghrelin levels to insulin therapy in children with newly diagnosed type 1 diabetes mellitus. Pediatr Res 2004; 55: 830-835.
18. Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S. Role of ghrelin in streptozotocin-induced diabetic hyperphagisa. Endocrinology 2002; 143: 4934-4937.
19. Masaoka T, Hidekazu S, Hosoda H, Takayuki O, Minegishi Y, Nagata H, Kangawa K, Ishii H. Enhanced plasma ghrelin levels in rats with STZ-induced diabetes. FEBS Lett 2003; 541: 64-68.
20. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, Van der Lely AJ, Deghenghi R, Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach induces hyperglycemia and reduces insulin secretion in man. J Clin Endocrinol Metab 2001; 86: 5083-5086.
21. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K, Sugihara S. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002; 51: 3408-3411.
22. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco G. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146: 241-244.
23. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S. Ghrelin is present in pancreatic alpha cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-129.
24. Adeghate E, Ponery AS. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 2002; 14: 555-560.
25. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kajima M, Kangawa K, Chihara K. Ghrelin modulates the downstream of insulin signaling in hepatoma cells. J Biol Chem 2002; 277: 5667-5674.
26. Schaller G., Schmidt A, Pleiner J, Woloszczuk W, Woltz M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin. Diabetes 2003; 52: 16-20.
27. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143: 185-190.
28. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
29. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
30. Ukkola O. Peripheral regulation of food intake: new insights. J Endocrinol Invest 2004; 27: 96-98.
31. Bellone S, Rapa A., Vivenza D, Castellino N, Petri A, Bellone J, Me E, Broglio F, Prodam F, Ghigo E, Bona G. Circulating ghrelin levels as function of gender, pubertal status and adiposity in childhood. J Endocrinol Invest 2002; 25: RC13-15.
32. Whatmore AJ, Hall CM, Jones J, Westwood M, Clayton PE. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol 2003; 59: 649-654.
33. Janssen JA, Van der Toorn FM, Hofland LJ, Van Koetsveld P, Broglio F, Ghigo E, Lamberts SW, Jan Van der Lely A. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by 1 year of growth hormone replacement therapy. Eur J Endocrinol 2001; 145: 711-716.